Anti-saccharomyces cerevisiae autoantibodies in autoimmune diseases: From bread baking to autoimmunity

Clinical Reviews in Allergy and Immunology

Volumn 45, Issue 2, 2013, Pages 152-161

  Rinaldi, Maurizio ^a   Perricone, Roberto ^a   Blank, Miri ^b   Perricone, Carlo ^c   Shoenfeld, Yehuda ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b TEL AVIV UNIVERSITY   (Israel)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Anti Saccharomyces cerevisiae autoantibodies; Autoantigenicity; Autoimmune diseases; Molecular mimicry; Vaccines

Indexed keywords

AUTOANTIBODY; BACTERIUM ANTIBODY; MANNAN; SACCHAROMYCES CEREVISIAE AUTOANTIBODY; SMALL NUCLEAR RIBONUCLEOPROTEIN; UNCLASSIFIED DRUG;

ANTIGEN BINDING; ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BIOINFORMATICS; COMMENSAL; CROHN DISEASE; HUMAN; IMMUNOASSAY; INSULIN DEPENDENT DIABETES MELLITUS; MOLECULAR MIMICRY; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PEYER PATCH; REVIEW; RHEUMATOID ARTHRITIS; SACCHAROMYCES CEREVISIAE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; COMPUTATIONAL BIOLOGY; HOMEOSTASIS; HUMANS; IMMUNE TOLERANCE; MICROBIOTA; RIBONUCLEOPROTEIN, U2 SMALL NUCLEAR; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS;

EID: 84884900815     PISSN: 10800549     EISSN: 15590267     Source Type: Journal    
DOI: 10.1007/s12016-012-8344-9     Document Type: Review

References (54)

1. Sicard D, Legras JL (2011) Bread, beer and wine: yeast domestication in the Saccharomyces sensu stricto complex. C R Biol 334(3):229-236
2. Krause I, Blank M, Cervera R, Font J, Matthias T, Pfeiffer S, Wies I, Fraser A, Shoenfeld Y (2007) Cross-reactive epitopes on β2-glycoprotein-I and Saccharomyces cerevisiae in patients with the antiphospholipid syndrome. Ann N Y Acad Sci 1108:481-488
3. Israeli E, Grotto I, Gilburd B, Balicer RD, Goldin E, Wiik A, Shoenfeld Y (2005) Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut 54(9):1232-1236
4. Dai H, Li Z, Zhang Y, Lv P, Gao XM (2009) Elevated levels of serum antibodies against Saccharomyces cerevisiae mannan in patients with systemic lupus erythematosus. Lupus 18(12):1087-1090
5. Sakly W, Mankaï A, Sakly N, Thabet Y, Achour A, Ghedira-Besbes L, Jeddi M, Ghedira I (2010) Anti-Saccharomyces cerevisiae antibodies are frequent in type 1 diabetes. Endocr Pathol 21(2):108-114
6. Dai H, Li Z, Zhang Y, Lv P, Gao XM (2009) Elevated levels of serum IgA against Saccharomyces cerevisiae mannan in patients with rheumatoid arthritis. Cell Mol Immunol 6(5):361-366
7. Agmon-Levin N, Lian Z, Shoenfeld Y (2011) Explosion of autoimmune diseases and the mosaic of old and novel factors. Cell Moll Immunol 8(3):189-192
8. Shoenfeld Y, Gilburd B, Abu-Shakra M, Amital H, Barzilai O, Berkun Y, Blank M, Zandman-Goddard G, Katz U, Krause I, Langevitz P, Levy Y, Orbach H, Pordeus V, Ram M, Sherer Y, Toubi E, Tomer Y (2008) The mosaic of autoimmunity: genetic factors involved in autoimmune diseases. Isr Med Assoc J 10(1):3-7
9. Shoenfeld Y, Zandman-Goddard G, Stojanovich L, Cutolo M, Amital H, Levy Y, Abu-Shakra M, Barzilai O, Berkun Y, Blank M, de Carvalho JF, Doria A, Gilburd B, Katz U, Krause I, Langevitz P, Orbach H, Pordeus V, Ram M, Toubi E, Sherer Y (2008) The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases-2008. Isr Med Assoc J 10:8-12
10. Shoenfeld Y, Blank M, Abu-Shakra M, Amital H, Barzilai O, Berkun Y, Bizzaro N, Gilburd B, Zandman-Goddard G, Katz U, Krause I, Langevitz P, Mackay IR, Orbach H, Ram M, Sherer Y, Toubi E, Gershwin ME (2008) The mosaic of autoimmunity: prediction, autoantibodies and therapy in autoimmune diseases-2008. Isr Med Assoc J 10(1):13-19
11. Proal AD, Albert PJ, Marshall T (2009) Autoimmune disease in the era of the metagenome. Autoimmun Rev 8:677-681
12. Kivity S, Agmon-Levin N, Blank M, Shoenfeld Y (2009) Infections and autoimmunity-friends or foes? Trends Immunol 30:409-414
13. Guilherme L, Kalil J, Cunningham M (2006) Molecular mimicry in the autoimmune pathogenesis of rheumatic heart disease. Autoimmunity 39(1):31-39
14. Duke RC (1989) Self recognition by T cells. I. Bystander killing of target cells bearing syngeneic MHC antigens. J Exp Med 1(170):59-71
15. Agmon-Levin N, Ram M, Barzilai O, Porat-Katz BS, Parikman R, Selmi C, Gershwin ME, Anaya JM, Youinou P, Bizzaro N, Tincani A, Tzioufas AG, Cervera R, Stojanovich L, Martin J, Gonzalez-Gay MA, Valentini G, Blank M, SanMarco M, Rozman B, Bombardieri S, De Vita S, Shoenfeld Y (2009) Prevalence of hepatitis C serum antibody in autoimmune diseases. J Autoimmun 32:261-266
16. Nahum A, Dadi H, Bates A, Roifman CM (2012) The biological significance of TLR3 variant, L412F, in conferring susceptibility to cutaneous candidiasis, CMV and autoimmunity. Autoimmun Rev 11:341-347
17. Villamón E, Gozalbo D, Roig P, Murciano C, O'Connor JE, Fradelizi D, Gil ML (2004) Myeloid differentiation factor 88 (MyD88) is required for murine resistance to Candida albicans and is critically involved in Candida-induced production of cytokines. Eur Cytokine Netw 15:263-271
18. Selmi C, Leung PS, Sherr DH, Diaz M, Nyland JF, Monestier M, Rose NR, Gershwin ME (2012) Mechanisms of environmental influence on human autoimmunity: a national institute of environmental health sciences expert panel workshop. J Autoimmun 28
19. Sarra M, Pallone F, Macdonald TT, Monteleone G (2010) IL-23/IL-17 axis in IBD. Inflamm Bowel Dis 16:1808-1813
20. Chervonsky AV (2010) Influence of microbial environment on autoimmunity. Nat Immunol 11:28-35
21. Fernández S, Molina IJ, Romero P, González R, Peña J, Sánchez F, Reynoso FR, Pérez-Navero JL, Estevez O, Ortega C, Santamaría M (2011) Characterization of gliadin-specific Th17 cells from the mucosa of celiac disease patients. Am J Gastroenterol 106:528-538
22. Bruce D, Yu S, Ooi JH, Cantorna MT (2011) Converging pathways lead to overproduction of IL-17 in the absence of vitamin D signaling. Int Immunol 23:519-528
23. Iborra M, Bernuzzi F, Invernizzi P, Danese S (2012) MicroRNAs in autoimmunity and inflammatory bowel disease: crucial regulators in immune response. Autoimmun Rev 11:305-314
24. O'Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D (2007) MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci U S A 30(104):1604-1609
25. Monk CE, Hutvagner G, Arthur JS (2010) Regulation of miRNA transcription in macrophages in response to Candida albicans. PLoS One 5:e13669
26. Thai TH, Calado DP, Casola S, Ansel KM, Xiao C, Xue Y, Murphy A, Frendewey D, Valenzuela D, Kutok JL, Schmidt-Supprian M, Rajewsky N, Yancopoulos G, Rao A, Rajewsky K (2007) Regulation of the germinal center response by microRNA-155. Science 316:604-608
27. Pordeus V, Szyper-Kravitz M, Levy RA, Vaz NM, Shoenfeld Y (2008) Infections and autoimmunity: a panorama. Clin Rev Allergy Immunol 34:283-299
28. Levin LI, Munger KL, Rubertone MV, Peck CA, Lennette ET, Spiegelman D, Ascherio A (2005) Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. JAMA 293:2496-2500
29. Shinohara H, Nagi-Miura N, Ishibashi K, Adachi Y, Ishida-Okawara A, Oharaseki T, Takahashi K, Naoe S, Suzuki K, Ohno N (2006) Beta-mannosyl linkages negatively regulate anaphylaxis and vasculitis in mice, induced by CAWS, fungal PAMPS composed of mannoprotein-beta-glucan complex secreted by Candida albicans. Biol Pharm Bull 29:1854-1861
30. Sorensen R, Thiel S, Jensenius JC (2005) Mannan-binding-lectin-associated serine proteases, characteristics and disease associations. Springer Semin Immunopathol 27:299-319
31. Standaert-Vitse A, Jouault T, Vandewalle P, Mille C, Seddik M, Sendid B, Mallet JM, Colombel JF, Poulain D (2006) Candida albicans is an immunogen for anti-Saccharomyces cerevisiae antibody markers of Crohn's disease. Gastroenterology 130:1764-1775
32. Lidar M, Langevitz P, Shoenfeld Y (2009) The role of infection in inflammatory bowel disease: initiation, exacerbation and protection. Isr Med Assoc J 11:558-563
33. Luong M, Lam JS, Chen J, Levitz SM (2007) Effects of fungal N- and O-linked mannosylation on the immunogenicity of model vaccines. Vaccine 25(22):4340-4344
34. Ardiani A, Higgins JP, Hodge JW (2010) Vaccines based on whole recombinant Saccharomyces cerevisiae cells. FEMS Yeast Res 10(8):1060-1069
35. Haller AA, Lauer GM, King TH, Kemmler C, Fiolkoski V, Lu Y, Bellgrau D, Rodell TC, Apelian D, Franzusoff A, Duke RC (2007) Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCV NS3 and Core proteins. Vaccine 25:1452-1463
36. van de Veerdonk FL, Kullberg BJ, van der Meer JW, Gow NA, Netea MG (2008) Host-microbe interactions: innate pattern recognition of fungal pathogens. Curr Opin Microbiol 11:305-312
37. Shoenfeld Y, Agmon-Levin N (2010) ASIA-autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun 36(1):4-8
38. Israeli E, Agmon-Levin N, Blank M, Shoenfeld Y (2009) Adjuvants and autoimmunity. Lupus 18(13):1217-1225
39. Agmon-Levin N, Paz Z, Israeli E, Shoenfeld Y (2009) Vaccines and autoimmunity. Nat Rev Rheumatol 5(11):648-652
40. Offit PA, Jew RK (2003) Addressing parents' concerns: do vaccines contain harmful preservatives, adjuvants, additives, or residuals? Pediatrics 112(6):1394-1397
41. Moore M, Fabricatorian D, Selby W (2002) Assessment and relevance of enzyme-linked immunosorbent assay for antibodies to Saccharomyces cerevisiae in Australian patients with inflammatory bowel disease. Inter Med J 32(7):349-352
42. Cinemre H, Bilir C, Gokosmanoglu F, Kadakal F (2007) Anti-Saccharomyces cerevisiae antibodies in acute myocardial infarction. J Investig Med 55(8):444-449
43. Jager NA, Teteloshvili N, Zeebregts CJ, Westra J, Bijl M (2012) Macrophage folate receptor-β (FR-β) expression in auto-immune inflammatory rheumatic diseases: a forthcoming marker for cardiovascular risk? Autoimmun Rev 11:621-626
44. Krause I, Weinberger A (2008) Behçet's disease. Krause I. Curr Opin Rheumatol 20(1):82-87
45. Choi CH, Kim TI, Kim BC, Shin SJ, Lee SK, Kim WH, Kim HS (2006) Anti-Saccharomyces cerevisiae antibody in intestinal Behçet's disease patients: relation to clinical course. Dis Colon Rectum 49(12):1849-1859
46. Rho YH, Chung CP, Oeser A, Solus J, Asanuma Y, Sokka T, Pincus T, Raggi P, Gebretsadik T, Shintani A, Stein CM (2009) Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis. Arthritis Rheum 61(11):1580-1585
47. YazIcI D, AydIn SZ, Yavuz D, TarçIn O, Deyneli O, Direskeneli H, AkalIn S (2010) Anti-Saccharomyces Cerevisiae antibodies (ASCA) are elevated in autoimmune thyroid disease ASCA in autoimmune thyroid disease. Endocrine 38(2):194-198
48. Barta Z, Zold E, Nagy A, Zeher M, Csipo I (2011) Celiac disease and microscopic colitis: a report of 4 cases. World J Gastroenterol 17(16):2150-2154
49. Lidar M, Langevitz P, Barzilai O, Ram M, Porat-Katz BS, Bizzaro N, Tonutti E, Maieron R, Chowers Y, Bar-Meir S, Shoenfeld Y (2009) Infectious serologies and autoantibodies in inflammatory bowel disease: insinuations at a true pathogenic role. Ann N Y Acad Sci 1173:640-648
50. Fagoonee S, De Luca L, De Angelis C, Castelli A, Rizzetto M, Pellicano R (2009) Anti-Saccharomyces cerevisiae as unusual antibodies in autoimmune hepatitis. Minerva Gastroenterol Dietol 55:37-40
51. Bueno de Mesquita M, Ferrante M, Henckaerts L, Joossens M, Janssens V, Hlavaty T, Pierik M, Joossens S, Van Schuerbeek N, Van Assche G, Rutgeerts P, Vermeire S, Hoffman I (2009) Clustering of (auto)immune diseases with early-onset and complicated inflammatory bowel disease. Eur J Pediatr 168(5):575-583
52. Czaja AJ, Shums Z, Donaldson PT, Norman GL (2004) Frequency and significance of antibodies to Saccharomyces cerevisiae in autoimmune hepatitis. Dig Dis Sci 49(4):611-618
53. Muratori P, Muratori L, Guidi M, Maccariello S, Pappas G, Ferrari R, Gionchetti P, Campieri M, Bianchi FB (2003) Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases. Clin Exp Immunol 132(3):473-476
54. Fassler J, Cooper P (2008) BLAST glossary. 2011 Jul 14. In: BLAST® Help [Internet]. National Center for Biotechnology Information (US), Bethesda